Chris Poole

Aridhia Informatics Ltd. provides health and biomedical informatics services. It develops technology and capability that supports the management of chronic diseases, precision medicine, and biomedical research through the use of biomedical informatics and analytics. The company was founded in 2007 by David James Sibbald and Andrew D. Morris and is headquartered in Edinburgh, the United Kingdom.

Exco InTouch provides mobile patient communication and clinical management solutions. Its solutions enable sponsors, clinical research organizations and websites, find the right patients, maintain compliance and facilitate the collection of patient data. The firm also offers electronic patient reported outcomes (ePRO), eDiary and post marketing studies. The company was founded by Tim Davis and Mike Hansen in 2004 and is headquartered in Nottingham, the United Kingdom.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom.

Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.

The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010.

Scottish Equity Partners LLP (Scottish Equity Partners) is a private equity firm founded in 1991 by Gary de Vinchelez Le Sueur and Andrew S. Paterson. The firm is headquartered in London, the United Kingdom.

GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.

Jacobs Rimell Ltd. develops service fulfilment solutions for communications service providers. It centric solutions enable business and residential customers to self-select and adopt Internet Protocol (IP) based products and services. The company was founded by Philip Andew Lipscombre Rimell and David Franklyn Jacobs on September 18, 1997 and is headquartered in London, the United Kingdom.

Owlstone Medical Ltd. develops breathalyzer device for use in clinical diagnostics and precision medicine with applications in cancer, inflammatory and infectious disease. The firm offers Lonestar VOC Analyzer, ReCIVA Breath Sampler and ultraFAIMS products. It also offers consult, analyze, and discover, report and validation services. The company was founded by Paul Boyle and Alonso David Ruiz in 2004 and is headquartered in Cambridge, CA.

Closed Loop Medicine Ltd. operates as a new breed of therapeutics company focused on care pathways, outcomes and the provision of dynamic personalised regimens. It combines proven drugs with digital therapeutics enabling the digitisation and data capture of an entire care continuum. The company was founded by Felicity Sartain, Hakim Yadi, Paul Goldsmith, and David Cox in 2017 and is headquartered in London, the United Kingdom.

Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB.

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

British Science Association operates as a charity. It focuses on promotion and development of science. The association was founded in 1831 and is headquartered in London, the United Kingdom.

Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987.

Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom.

Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981.

IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom.

Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom.

PWC Corp. is a private company that wholesales steel water pipes and plumbing and heating equipment. The company is based in Santa Ana, CA.

Part of Mitsubishi UFJ Financial Group, Inc., Sanwa Bank Canada is a Canadian company that provides banking services. The company is based in Toronto, Canada.

Actis LLP (Actis) is a private equity firm founded in 1948 by Sreenivasulu Vudayagiri and Pavel Alexandrovich Cherkashin. The firm is headquartered in London, United Kingdom.

Aavishkaar Inc (Aavishkaar Capital) is a venture capital firm founded in 2001 by Vineet Chandra Rai. The firm is headquartered in Mumbai, India.

Pretzel Therapeutics, Inc. is an American biotechnology company that develops therapies by utilizing mitochondrial biology. Pretzel Therapeutics is based in an undisclosed location and has research facilities in another undisclosed location. The company aims to develop treatments that address the genetic causes of mitochondrial dysfunction. The company was founded by academic experts in mitochondrial biology and is supported by a world-class investor syndicate. Jay Parrish has been the CEO of the company since 2021.

Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom.

Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom.

Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom.

CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom.

Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom.

The National Deaf Children's Society is a leading charity that provides support and advice to deaf children and young people. The non-profit company is based in London, UK. The British company offers guidance to parents and carers on how to encourage deaf teenagers and young people to be honest about their mental health. The organization also provides information on children's social services and their role in supporting deaf children and their families. The company has safeguarding procedures in place to minimize risks to deaf children and young people. The company was founded in 1944. Susan Daniels has been the CEO of the company since 1992.

Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark.

KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom.